20
Chirogate International Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Chirogate is a professional Prostaglandin manufacturer.
One of their notable products is TRAVOPROST, with a corresponding US DMF Number 22738.
Remarkably, this DMF maintains an Active status since its submission on April 20, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 23, 2012, and payment made on December 17, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II